GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up

Background: GOLFIG is a chemo-immunotherapy regimen established in preclinical models that combines gemcitabine + FOLFOX (fluoropyrimidine backbone coupled to oxaliplatin) poly-chemotherapy with low-dose s. c. recombinant interleukin-2 (rIL-2) and granulocyte-macrophage colony stimulating factor (GM...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Oncol
Päätekijät: Caraglia, Michele, Correale, Pierpaolo, Giannicola, Rocco, Staropoli, Nicoletta, Botta, Cirino, Pastina, Pierpaolo, Nesci, Antonello, Caporlingua, Nadia, Francini, Edoardo, Ridolfi, Laura, Mini, Enrico, Roviello, Giandomenico, Ciliberto, Domenico, Agostino, Rita Maria, Strangio, Alessandra, Azzarello, Domenico, Nardone, Valerio, Falzea, Antonella, Cappabianca, Salvatore, Bocchetti, Marco, D'Arrigo, Graziella, Tripepi, Giovanni, Tassone, Pierfrancesco, Addeo, Raffaele, Giordano, Antonio, Pirtoli, Luigi, Francini, Guido, Tagliaferri, Pierosandro
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2019
Aiheet:
Oncology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6857002/
https://ncbi.nlm.nih.gov/pubmed/31781481
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.01102
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia